Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Muscle & Nerve|July 17, 2016
Clinical measures in transthyretin familial amyloid polyneuropathyTeresa Coelho, Aaron Vinik, Etta J Vinik, et al.
Journal of the American Heart Association|January 15, 2013
Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjectsJ Michael Gaziano, Anthony H Cincotta, Aaron Vinik, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Clinical case seminar: hypoglycemia after pancreas transplantation: association with allograft nesidiodysplasia and expression of islet neogenesis-associated peptideCrispin Semakula, Stefan Pambuccian, Rainer Gruessner, et al.
The Oncologist|April 25, 2019
Patterns of Care Among Real-World Patients with Metastatic Neuroendocrine TumorsAndrew J Klink, Bruce Feinberg, Hsing-Ting Yu, et al.
Clinical and Translational Science|January 19, 2021
Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factorJohn A Kessler, Aziz Shaibani, Christine N Sang, et al.
Southern Medical Journal|December 18, 2008
Blood B-type natriuretic peptide and dialysis: present assessment and future analysesMark Flemmer, Hussein Rajab, Tracy Mathena, et al.
Journal of Diabetes Research|June 11, 2015
Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes MellitusBindu Chamarthi, J Michael Gaziano, Lawrence Blonde, et al.
The Oncologist|October 18, 2017
Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label StudyGeorge A Fisher, Edward M Wolin, Nilani Liyanage, et al.
Annals of Clinical and Translational Neurology|May 23, 2015
Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathyJohn A Kessler, A Gordon Smith, Bong-Soo Cha, et al.
International Journal of Clinical Practice|February 7, 2021
Factors influencing the quality of life over a 4-year period of time in Romanian patients with diabetes mellitusCamelia Larisa Vonica, Norina Alinta Gâvan, Daniel-Tudor Cosma, et al.
Pageof 5